<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://podcastdemedicina.com/cp/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	>
		<channel>
		<title>MDS PODCAST: Defining Parkinson&#039;s disease</title>
		<atom:link href="https://podcastdemedicina.com/feed/podcast/mds-podcast-defining-parkinsons-disease/" rel="self" type="application/rss+xml"/>
		<link>https://podcastdemedicina.com/series/mds-podcast-defining-parkinsons-disease/</link>
		<description></description>
		<lastBuildDate>Wed, 15 Jul 2026 08:30:07 +0000</lastBuildDate>
		<language>es</language>
		<copyright>&#xA9; 2026 Podcast de Medicina · by casiMedicos</copyright>
		<itunes:subtitle>Plataforma de podcasts de medicina, salud y ciencia en formato audio, orientada a profesionales sanitarios, residentes MIR y estudiantes.</itunes:subtitle>
		<itunes:author>Podcast de Medicina · by casiMedicos</itunes:author>
		<itunes:summary></itunes:summary>
		<itunes:owner>
			<itunes:name>Podcast de Medicina · by casiMedicos</itunes:name>
		</itunes:owner>
		<itunes:explicit>false</itunes:explicit>
		<googleplay:author><![CDATA[Podcast de Medicina · by casiMedicos]]></googleplay:author>
						<googleplay:description></googleplay:description>
			<googleplay:explicit>No</googleplay:explicit>
			<podcast:locked>yes</podcast:locked>
		<podcast:guid>4eda0bf4-6e4e-586a-903c-7d2847c32eee</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/3.15.0" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=7.0.1</generator>

<item>
	<title>MDS Podcast Beyond the gene: Targeting neuroinflammation in Huntington&#8217;s disease</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-beyond-the-gene-targeting-neuroinflammation-in-huntingtons-disease/</link>
	<pubDate>Mon, 06 Jul 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-beyond-the-gene-targeting-neuroinflammation-in-huntingtons-disease/</guid>
	<description><![CDATA[Dr. Sarah Camargos is joined by Dr. Rajeev Kumar to explore early research on targeting neuroinflammation in Huntington&#8217;s disease. Dr. Kumar delves into the intricacies of the complement cascade, highlighting the pivotal role of C1q as the recognition molecule at the top of this immune system chain reaction and how ANX005 aims to prevent the...]]></description>
	<itunes:subtitle><![CDATA[Dr. Sarah Camargos is joined by Dr. Rajeev Kumar to explore early research on targeting neuroinflammation in Huntington&#8217;s disease. Dr. Kumar delves into the intricacies of the complement cascade, highlighting the pivotal role of C1q as the recognit]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Sarah Camargos is joined by Dr. Rajeev Kumar to explore early research on targeting neuroinflammation in Huntington&#8217;s disease. Dr. Kumar delves into the intricacies of the complement cascade, highlighting the pivotal role of C1q as the recognition molecule at the top of this immune system chain reaction and how ANX005 aims to prevent the...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-307----Beyond-the-gene_-Targeting-neuroinflammation-in-Huntingtons-disease.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Sarah Camargos is joined by Dr. Rajeev Kumar to explore early research on targeting neuroinflammation in Huntington&#8217;s disease. Dr. Kumar delves into the intricacies of the complement cascade, highlighting the pivotal role of C1q as the recognition molecule at the top of this immune system chain reaction and how ANX005 aims to prevent the...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Sarah Camargos is joined by Dr. Rajeev Kumar to explore early research on targeting neuroinflammation in Huntington&#8217;s disease. Dr. Kumar delves into the intricacies of the complement cascade, highlighting the pivotal role of C1q as the recognition molecule at the top of this immune system chain reaction and how ANX005 aims to prevent the...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Hot Topic: Argentine tango in the rehabilitation of persons with Parkinson&#8217;s disease</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-hot-topic-argentine-tango-in-the-rehabilitation-of-persons-with-parkinsons-disease/</link>
	<pubDate>Mon, 29 Jun 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-hot-topic-argentine-tango-in-the-rehabilitation-of-persons-with-parkinsons-disease/</guid>
	<description><![CDATA[Ms. Nicole Duff and Prof. Hae-Young Hawong discuss the benefits of Argentine tango in the rehabilitation of person&#8217;s with Parkinson disease. The motor, non-motor, social, and quality of life gains are all explored; in addition to, the neuro-anatomical, neurophysiological and neuroplastic benefits. Prof. Hawong also describes the very successful and passion-based Argentine tango program she...]]></description>
	<itunes:subtitle><![CDATA[Ms. Nicole Duff and Prof. Hae-Young Hawong discuss the benefits of Argentine tango in the rehabilitation of person&#8217;s with Parkinson disease. The motor, non-motor, social, and quality of life gains are all explored; in addition to, the neuro-anatomi]]></itunes:subtitle>
	<content:encoded><![CDATA[Ms. Nicole Duff and Prof. Hae-Young Hawong discuss the benefits of Argentine tango in the rehabilitation of person&#8217;s with Parkinson disease. The motor, non-motor, social, and quality of life gains are all explored; in addition to, the neuro-anatomical, neurophysiological and neuroplastic benefits. Prof. Hawong also describes the very successful and passion-based Argentine tango program she...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-306---Hot-Topic_-Argentine-tango-in-the-rehabilitation-of-persons-with-Parkinsons-disease.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Ms. Nicole Duff and Prof. Hae-Young Hawong discuss the benefits of Argentine tango in the rehabilitation of person&#8217;s with Parkinson disease. The motor, non-motor, social, and quality of life gains are all explored; in addition to, the neuro-anatomical, neurophysiological and neuroplastic benefits. Prof. Hawong also describes the very successful and passion-based Argentine tango program she...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Ms. Nicole Duff and Prof. Hae-Young Hawong discuss the benefits of Argentine tango in the rehabilitation of person&#8217;s with Parkinson disease. The motor, non-motor, social, and quality of life gains are all explored; in addition to, the neuro-anatomical, neurophysiological and neuroplastic benefits. Prof. Hawong also describes the very successful and passion-based Argentine tango program she...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Blocking alpha-synuclein propagation with perampanel</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-blocking-alpha-synuclein-propagation-with-perampanel/</link>
	<pubDate>Mon, 22 Jun 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-blocking-alpha-synuclein-propagation-with-perampanel/</guid>
	<description><![CDATA[Dr. Norihito Uemura joins Prof. Tiago Outeiro to discuss perampanel, an AMPA receptor antagonist, and how it has been shown to block alpha-synuclein propagation and neurodegeneration in a mouse model of Lewy body disease. Dr. Uemura explains the mechanistic findings of transsynaptic propagation and the study limitations pertaining to mouse behavior. They also discuss perampanel’s...]]></description>
	<itunes:subtitle><![CDATA[Dr. Norihito Uemura joins Prof. Tiago Outeiro to discuss perampanel, an AMPA receptor antagonist, and how it has been shown to block alpha-synuclein propagation and neurodegeneration in a mouse model of Lewy body disease. Dr. Uemura explains the mechanis]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Norihito Uemura joins Prof. Tiago Outeiro to discuss perampanel, an AMPA receptor antagonist, and how it has been shown to block alpha-synuclein propagation and neurodegeneration in a mouse model of Lewy body disease. Dr. Uemura explains the mechanistic findings of transsynaptic propagation and the study limitations pertaining to mouse behavior. They also discuss perampanel’s...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-305---Blocking-alpha-synuclein-propagation-with-perampanel-CME.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Norihito Uemura joins Prof. Tiago Outeiro to discuss perampanel, an AMPA receptor antagonist, and how it has been shown to block alpha-synuclein propagation and neurodegeneration in a mouse model of Lewy body disease. Dr. Uemura explains the mechanistic findings of transsynaptic propagation and the study limitations pertaining to mouse behavior. They also discuss perampanel’s...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Norihito Uemura joins Prof. Tiago Outeiro to discuss perampanel, an AMPA receptor antagonist, and how it has been shown to block alpha-synuclein propagation and neurodegeneration in a mouse model of Lewy body disease. Dr. Uemura explains the mechanistic findings of transsynaptic propagation and the study limitations pertaining to mouse behavior. They also discuss perampanel’s...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast End of life preferences of people with Parkinson&#8217;s disease</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-end-of-life-preferences-of-people-with-parkinsons-disease/</link>
	<pubDate>Mon, 15 Jun 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-end-of-life-preferences-of-people-with-parkinsons-disease/</guid>
	<description><![CDATA[Ms. Nicole Duff and Dr. Marjan Meinders discuss end of life preferences of people with Parkinson’s disease. Together they discuss the ways that end-of-life records could be sourced, as well as what information could be found in the end-of-life record. They further dive into the differences between specific European countries and the reasons around the...]]></description>
	<itunes:subtitle><![CDATA[Ms. Nicole Duff and Dr. Marjan Meinders discuss end of life preferences of people with Parkinson’s disease. Together they discuss the ways that end-of-life records could be sourced, as well as what information could be found in the end-of-life record. Th]]></itunes:subtitle>
	<content:encoded><![CDATA[Ms. Nicole Duff and Dr. Marjan Meinders discuss end of life preferences of people with Parkinson’s disease. Together they discuss the ways that end-of-life records could be sourced, as well as what information could be found in the end-of-life record. They further dive into the differences between specific European countries and the reasons around the...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-304---End-of-life-preferences-of-people-with-Parkinsons-disease.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Ms. Nicole Duff and Dr. Marjan Meinders discuss end of life preferences of people with Parkinson’s disease. Together they discuss the ways that end-of-life records could be sourced, as well as what information could be found in the end-of-life record. They further dive into the differences between specific European countries and the reasons around the...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Ms. Nicole Duff and Dr. Marjan Meinders discuss end of life preferences of people with Parkinson’s disease. Together they discuss the ways that end-of-life records could be sourced, as well as what information could be found in the end-of-life record. They further dive into the differences between specific European countries and the reasons around the...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Quality of life in Parkinson’s disease</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-quality-of-life-in-parkinsons-disease/</link>
	<pubDate>Mon, 08 Jun 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-quality-of-life-in-parkinsons-disease/</guid>
	<description><![CDATA[Dr. Connie Marras discusses with Dr. Sara Schaefer her recent study in Movement Disorders Clinical Practice exploring the perspective of Persons with Parkinson&#8217;s disease on the definition of quality of life. Read the article.]]></description>
	<itunes:subtitle><![CDATA[Dr. Connie Marras discusses with Dr. Sara Schaefer her recent study in Movement Disorders Clinical Practice exploring the perspective of Persons with Parkinson&#8217;s disease on the definition of quality of life. Read the article.]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Connie Marras discusses with Dr. Sara Schaefer her recent study in Movement Disorders Clinical Practice exploring the perspective of Persons with Parkinson&#8217;s disease on the definition of quality of life. Read the article.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-303---Quality-of-life-in-Parkinsons-disease.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Connie Marras discusses with Dr. Sara Schaefer her recent study in Movement Disorders Clinical Practice exploring the perspective of Persons with Parkinson&#8217;s disease on the definition of quality of life. Read the article.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Connie Marras discusses with Dr. Sara Schaefer her recent study in Movement Disorders Clinical Practice exploring the perspective of Persons with Parkinson&#8217;s disease on the definition of quality of life. Read the article.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast New data to reframe the risks of DBS surgery for patients and providers</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-new-data-to-reframe-the-risks-of-dbs-surgery-for-patients-and-providers/</link>
	<pubDate>Mon, 01 Jun 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-new-data-to-reframe-the-risks-of-dbs-surgery-for-patients-and-providers/</guid>
	<description><![CDATA[Myths and misconceptions related to the surgical risks of deep brain stimulation (DBS) procedures remain common despite many years of evidence demonstrating its relative safety. This leads to both patient and provider fear in referring eligible patients for consideration of a potentially life-altering therapy for symptom management in many movement disorders. Dr. Mitra Afshari speaks...]]></description>
	<itunes:subtitle><![CDATA[Myths and misconceptions related to the surgical risks of deep brain stimulation (DBS) procedures remain common despite many years of evidence demonstrating its relative safety. This leads to both patient and provider fear in referring eligible patients ]]></itunes:subtitle>
	<content:encoded><![CDATA[Myths and misconceptions related to the surgical risks of deep brain stimulation (DBS) procedures remain common despite many years of evidence demonstrating its relative safety. This leads to both patient and provider fear in referring eligible patients for consideration of a potentially life-altering therapy for symptom management in many movement disorders. Dr. Mitra Afshari speaks...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-302---New-data-to-reframe-the-risks-of-DBS-surgery-for-patients-and-providers.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Myths and misconceptions related to the surgical risks of deep brain stimulation (DBS) procedures remain common despite many years of evidence demonstrating its relative safety. This leads to both patient and provider fear in referring eligible patients for consideration of a potentially life-altering therapy for symptom management in many movement disorders. Dr. Mitra Afshari speaks...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Myths and misconceptions related to the surgical risks of deep brain stimulation (DBS) procedures remain common despite many years of evidence demonstrating its relative safety. This leads to both patient and provider fear in referring eligible patients for consideration of a potentially life-altering therapy for symptom management in many movement disorders. Dr. Mitra Afshari speaks...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Ataxia Series: Treating cerebellar ataxia in 2026 &#8211; What&#8217;s new?</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-ataxia-series-treating-cerebellar-ataxia-in-2026-whats-new/</link>
	<pubDate>Tue, 26 May 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-ataxia-series-treating-cerebellar-ataxia-in-2026-whats-new/</guid>
	<description><![CDATA[For many years ataxias, especially the genetic forms, were considered untreatable diseases. In this episode Dr. Orlando Barsottini and Dr. Liana Rosenthal discuss the new advances in the treatment of ataxias and perspectives for the future.]]></description>
	<itunes:subtitle><![CDATA[For many years ataxias, especially the genetic forms, were considered untreatable diseases. In this episode Dr. Orlando Barsottini and Dr. Liana Rosenthal discuss the new advances in the treatment of ataxias and perspectives for the future.]]></itunes:subtitle>
	<content:encoded><![CDATA[For many years ataxias, especially the genetic forms, were considered untreatable diseases. In this episode Dr. Orlando Barsottini and Dr. Liana Rosenthal discuss the new advances in the treatment of ataxias and perspectives for the future.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-301----Ataxia-Series_-Treating-Cerebellar-Ataxia-in-2026---Whats-New_.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[For many years ataxias, especially the genetic forms, were considered untreatable diseases. In this episode Dr. Orlando Barsottini and Dr. Liana Rosenthal discuss the new advances in the treatment of ataxias and perspectives for the future.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[For many years ataxias, especially the genetic forms, were considered untreatable diseases. In this episode Dr. Orlando Barsottini and Dr. Liana Rosenthal discuss the new advances in the treatment of ataxias and perspectives for the future.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Prodromal autonomic dysfunction in Lewy body diseases</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-prodromal-autonomic-dysfunction-in-lewy-body-diseases/</link>
	<pubDate>Mon, 18 May 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-prodromal-autonomic-dysfunction-in-lewy-body-diseases/</guid>
	<description><![CDATA[Prodromal autonomic dysfunction has emerged as an important area of research in understanding Lewy body diseases, including Parkinson&#8217;s disease, and dementia with Lewy bodies. Dr. Michelle Matarazzo sits down with three experts in the field, Dr. Abhimanyu Mahajan, Dr. Alison Yarnall, and Dr. David Goldstein to discuss the current evidence behind various disturbances and how...]]></description>
	<itunes:subtitle><![CDATA[Prodromal autonomic dysfunction has emerged as an important area of research in understanding Lewy body diseases, including Parkinson&#8217;s disease, and dementia with Lewy bodies. Dr. Michelle Matarazzo sits down with three experts in the field, Dr. Ab]]></itunes:subtitle>
	<content:encoded><![CDATA[Prodromal autonomic dysfunction has emerged as an important area of research in understanding Lewy body diseases, including Parkinson&#8217;s disease, and dementia with Lewy bodies. Dr. Michelle Matarazzo sits down with three experts in the field, Dr. Abhimanyu Mahajan, Dr. Alison Yarnall, and Dr. David Goldstein to discuss the current evidence behind various disturbances and how...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-300---Prodromal-autonomic-dysfunction-in-Lewy-body-diseases.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Prodromal autonomic dysfunction has emerged as an important area of research in understanding Lewy body diseases, including Parkinson&#8217;s disease, and dementia with Lewy bodies. Dr. Michelle Matarazzo sits down with three experts in the field, Dr. Abhimanyu Mahajan, Dr. Alison Yarnall, and Dr. David Goldstein to discuss the current evidence behind various disturbances and how...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Prodromal autonomic dysfunction has emerged as an important area of research in understanding Lewy body diseases, including Parkinson&#8217;s disease, and dementia with Lewy bodies. Dr. Michelle Matarazzo sits down with three experts in the field, Dr. Abhimanyu Mahajan, Dr. Alison Yarnall, and Dr. David Goldstein to discuss the current evidence behind various disturbances and how...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Ataxia Series: Beyond the cerebellum &#8211; Non-motor features and multisystem care in genetic ataxias</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-ataxia-series-beyond-the-cerebellum-non-motor-features-and-multisystem-care-in-genetic-ataxias/</link>
	<pubDate>Mon, 11 May 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-ataxia-series-beyond-the-cerebellum-non-motor-features-and-multisystem-care-in-genetic-ataxias/</guid>
	<description><![CDATA[Genetic ataxias have many non-motor features, such as fatigue, sleep disorders, and cognitive dysfunction. In this episode, Dr. Orlando Barsottini and Dr. Christofer Stephen discuss the most common non-motor symptoms and how to approach them.]]></description>
	<itunes:subtitle><![CDATA[Genetic ataxias have many non-motor features, such as fatigue, sleep disorders, and cognitive dysfunction. In this episode, Dr. Orlando Barsottini and Dr. Christofer Stephen discuss the most common non-motor symptoms and how to approach them.]]></itunes:subtitle>
	<content:encoded><![CDATA[Genetic ataxias have many non-motor features, such as fatigue, sleep disorders, and cognitive dysfunction. In this episode, Dr. Orlando Barsottini and Dr. Christofer Stephen discuss the most common non-motor symptoms and how to approach them.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-299----Ataxia-Series_-Beyond-the-cerebellum---Non-motor-features-and-multisystem-care-in-genetic-ataxias.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Genetic ataxias have many non-motor features, such as fatigue, sleep disorders, and cognitive dysfunction. In this episode, Dr. Orlando Barsottini and Dr. Christofer Stephen discuss the most common non-motor symptoms and how to approach them.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Genetic ataxias have many non-motor features, such as fatigue, sleep disorders, and cognitive dysfunction. In this episode, Dr. Orlando Barsottini and Dr. Christofer Stephen discuss the most common non-motor symptoms and how to approach them.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Modulating the peripheral immune response: LRRK2 and GBA1 mutations</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-modulating-the-peripheral-immune-response-lrrk2-and-gba1-mutations/</link>
	<pubDate>Mon, 04 May 2026 03:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-modulating-the-peripheral-immune-response-lrrk2-and-gba1-mutations/</guid>
	<description><![CDATA[Dr. Michele Matarazzo sits down with Dr. Rebecca Wallings to discuss  how two of the most important genetic forms for Parkinson&#8217;s disease, LRRK2 and GBA1, influence immune response to bacterial simulation. Their discussion highlights a potential link between genetics, environment, and inflammation in Parkinson’s disease. Journal CME is available until March 18, 2027 Read the...]]></description>
	<itunes:subtitle><![CDATA[Dr. Michele Matarazzo sits down with Dr. Rebecca Wallings to discuss  how two of the most important genetic forms for Parkinson&#8217;s disease, LRRK2 and GBA1, influence immune response to bacterial simulation. Their discussion highlights a potential li]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Michele Matarazzo sits down with Dr. Rebecca Wallings to discuss  how two of the most important genetic forms for Parkinson&#8217;s disease, LRRK2 and GBA1, influence immune response to bacterial simulation. Their discussion highlights a potential link between genetics, environment, and inflammation in Parkinson’s disease. Journal CME is available until March 18, 2027 Read the...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-298---Modulating-the-peripheral-immune-response_-LRRK2-and-GBA1-mutations-CME.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Michele Matarazzo sits down with Dr. Rebecca Wallings to discuss  how two of the most important genetic forms for Parkinson&#8217;s disease, LRRK2 and GBA1, influence immune response to bacterial simulation. Their discussion highlights a potential link between genetics, environment, and inflammation in Parkinson’s disease. Journal CME is available until March 18, 2027 Read the...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Michele Matarazzo sits down with Dr. Rebecca Wallings to discuss  how two of the most important genetic forms for Parkinson&#8217;s disease, LRRK2 and GBA1, influence immune response to bacterial simulation. Their discussion highlights a potential link between genetics, environment, and inflammation in Parkinson’s disease. Journal CME is available until March 18, 2027 Read the...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
